Search

Search Constraints

You searched for: Issue Volume 35(2020)Supplement 3

Search Results

31. MO018CARDIOVASCULAR EFFECTS OF UNILATERAL NEPHRECTOMY IN LIVING KIDNEY DONORS AT FIVE YEARS. (6th June 2020)

33. MO020EFFICACY AND SAFETY OF THE LONG-ACTING C5 INHIBITOR RAVULIZUMAB IN PATIENTS WITH POSTPARTUM ATYPICAL HAEMOLYTIC URAEMIC SYNDROME. (6th June 2020)

35. MO022URINARY PHOSPHATE/UREA RATIO, A NEW TOOL TO EVALUATE ADHERENCE TO PHOSPHATE DIETARY INTERVENTIONS IN CKD PATIENTS. (6th June 2020)

37. MO024WHAT IS THE BEST PREDICTABLE LIPID SUBFRACTION FOR CARDIOVASCULAR OUTCOMES AND ALL-CAUSE MORTALITY IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE?. (6th June 2020)

38. MO025ADVANCED GLYCATION END PRODUCTS (AGES) AND SOLUBLE RECEPTOR FOR AGES (SRAGE): ASSOCIATION WITH RISK OF MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS. (6th June 2020)

39. MO026TREATMENT WITH ACTIVE VITAMIN D DOES NOT IMPROVE LEFT VENTRICULAR HYPERTROPHY BUT FURTHER INCREASES FGF23 AND ACCELERATES CKD PROGRESSION IN CHILDREN. (6th June 2020)

40. MO027EVALUATING THE FEASIBILITY AND IMPACT OF A MOBILE PHONE TEXT MESSAGING INTERVENTION ON ADHERENCE TO DIETARY RECOMMENDATIONS IN PATIENTS ON HAEMODIALYSIS (KIDNEYTEXT). (6th June 2020)